Shenzhen Chuangyingxin Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Chuangyingxin Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AIKALOR. The owner is based in Shenzhen City.

5F, Bldg.1, Xiazao Village, Gaofeng

Community, Dalang St.,Longhua Dist.

Shenzhen City 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AIKALOR
AIKALOR
Registered 2020

Trademark Classifications

Shenzhen Chuangyingxin Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Chuangyingxin Technology Co., Ltd. have?

Shenzhen Chuangyingxin Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Chuangyingxin Technology Co., Ltd. file in?

Shenzhen Chuangyingxin Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Chuangyingxin Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Chuangyingxin Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as AIKALOR. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Chuangyingxin Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Chuangyingxin Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.